Skip to main content

Cyclic AMP Metabolism in Intact Rat Ventricular Cardiac Myocytes: Interaction of Carbachol with Isoproterenol and 3-Isobutyl-L-Methylxanthine

  • Chapter
Book cover Cellular Function and Metabolism

Part of the book series: Developments in Molecular and Cellular Biochemistry ((DMCB,volume 9))

  • 87 Accesses

Abstract

Experiments were carried out to elucidate the characteristics of regulation of cyclic AMP levels in intact myocardial cells. For this purpose, the influence of isoproterenol, a nonselective cyclic nucleotide phosphodiesterase (PDE) inhibitor 3-isobutyl-l-methylxanthine (IBMX) and carbachol on cyclic AMP levels was investigated in isolated rat cardiac myocytes. The extent of cyclic AMP accumulation induced by isoproterenol was much less than that produced by IBMX: submaximal concentrations of isoproterenol and IBMX elevated the cyclic AMP level 2.4- and 4.8-fold of the control level, respectively. Both agents in combination increased the cyclic AMP level markedly 48-fold. Carbachol inhibited the cyclic AMP accumulation induced by isoproterenol, IBMX and their combination by 30%, 60% and 80% of the respective response. The extent of inhibition produced by carbachol of the cyclic AMP accumulation induced by IBMX + isoproterenol was smaller than that caused by propranolol, and carbachol produced only a marginal additional inhibitory action to that of propranolol, implying that carbachol does not affect the process of cyclic AMP degradation. The present findings indicate that in intact cardiac myocytes the rate of cyclic AMP degradation catalyzed by PDE may be a crucial process of cyclic AMP turnover. This view is supported by the observations that the inhibitory action of carbachol on the effect of isoproterenol was less than that on the effect of IBMX, and that the inhibitory action of carbachol was markedly enhanced by the simultaneous presence of IBMX. (Mol Cell Biochem 119: 195–201, 1993)

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Biegon RL, Epstein PM, Pappano AJ: Muscarinic antagonism of the effects of a phosphodiesterase inhibitor (methylisobutylxan-thine) in embryonic chick ventricle. J Pharmacol Exp Ther 215: 348–356, 1980

    PubMed  CAS  Google Scholar 

  2. Hollenberg M, Carriere S, Barger AC: Biphasic action of ace-tylcholine on ventricular myocardium. Circ Res 16: 527–536, 1965

    Article  PubMed  CAS  Google Scholar 

  3. Löffelholz K, Pappano AJ: The parasympathetic neuroeffector junction of the heart. Pharmacol Rev 37: 1–24, 1985

    PubMed  Google Scholar 

  4. Levy MN: Sympathetic-parasympathetic interactions in the heart. Circ Res 29: 437–445, 1971

    Article  PubMed  CAS  Google Scholar 

  5. Birnbaumer L, Codina J, Sunyer T, Hildebrandt JD, Sekura RD, Cerione RA, Lefkowitz RJ, Caron MG: Dual coupling mechanisms in the regulation of cAMP formation. In: AM Gotto Jr and BW O’Malley (eds). The role of receptors in biology and medicine. Raven Press, New York, 1986, p 193–211

    Google Scholar 

  6. Gilman AG: G proteins: transducers of receptor-regulated signals. Ann Rev Biochem 56: 615–649, 1987

    Article  PubMed  CAS  Google Scholar 

  7. Ui M, Katada T, Maruyama T, Kurose H, Yajima M, Tamura M, Nakamura T, Nogimori K: Islet-activating protein, pertussis toxin: a specific uncoupler of receptor-mediated inhibition of adenylate cyclase. Adv Cyclic Nucleotide Protein Phosphorylation Res 17: 145–151, 1984

    PubMed  CAS  Google Scholar 

  8. Thompson WJ, Pratt ML, Strada SJ: Biochemical properties of high-affinity cyclic AMP phosphodiesterases. Adv Cyclic Protein Phosphorylation Res 16: 137–148, 1984

    CAS  Google Scholar 

  9. Weishaar RE, Kobylarz-Singer D, Reiser JA, Wright CD, Cornicelli J, Panek R: Cyclic nucleotide phosphodiesterases in the circulatory system. Biochemical, pharmacological, and functional characteristics. Adv Cyclic Protein Phosphorylation Res 25: 249–269, 1992

    CAS  Google Scholar 

  10. Powell T, Twist VW: A rapid technique for the isolation and purification of adult cardiac muscle cells having respiratory control and a tolerance to calcium. Biochem Biophys Res Commun 72: 327–333, 1976

    Article  PubMed  CAS  Google Scholar 

  11. Katada T, Ui M: Islet activating protein: enhanced insulin secretion and cyclic AMP accumulation in pancreatic islets due to activation of native calcium ionophores. J Biol Chem 254: 469–479, 1979

    PubMed  CAS  Google Scholar 

  12. Murad F, Chi YM, Rail TW, Sutherland EW: Adenyl cyclase: II. The effect of catecholamines and choline esters on the formation of adenosine-3′-5′-monophosphate by preparations from cardiac muscle and liver. J Biol Chem 237: 1233–1238, 1962

    PubMed  CAS  Google Scholar 

  13. Lindemann JP, Watanabe AM: Muscariniccholinergicinhibition of β-adrenergic stimulation of phospholamban phosphorylation and Ca2+ transport in guinea pig ventricles. J Biol Chem 260: 13122–13129, 1985

    PubMed  CAS  Google Scholar 

  14. Brown BS, Poison JB, Krzanowski JJ, Wiggins JA: Influence of isoproterenol and methylisobutylxanthine on the contractile and cyclic nucleotide effects of methacholine in isolated rat atria. J Pharmacol Exp Ther 212: 325–332, 1980

    PubMed  CAS  Google Scholar 

  15. Endoh M: Dual inhibition of myocardial function through muscarinic and adenosine receptors in the mammalian heart. J Appl Cardiol 2: 213–230, 1987

    CAS  Google Scholar 

  16. Chasin M, Harris DN: Inhibitors and activators of cyclic nucleotide phosphodiesterase. Adv Cyclic Nucleotide Res 7: 225–264, 1976

    PubMed  CAS  Google Scholar 

  17. Korth M: Effects of several phosphodiesterase-inhibitors on guinea-pig myocardium. Naunyn-Schmiedeberg’s Arch Pharmacol 302: 77–86, 1978

    Article  CAS  Google Scholar 

  18. Weishaar RE, Cain MH, Bristol JA: A new generation of phosphodiesterase inhibitors: Multiple molecular forms of phosphodiesterase and the potential for drug selectivity. J Med Chem 28: 537–545, 1985

    Article  PubMed  CAS  Google Scholar 

  19. Meeker RB, Harden TK: Muscarinic cholinergic receptor-mediated activation of phosphodiesterase. Mol Pharmacol 22: 310–319, 1982

    PubMed  CAS  Google Scholar 

  20. Parsons WJ, Ramkumar V, Stiles GL: Isobutylmethylxanthine stimulates adenylate cyclase by blocking the inhibitory regulatory protein, Gi. Mol Pharmacol 34: 37–41, 1988

    PubMed  CAS  Google Scholar 

  21. Lavan BE, Lakey T, Houselay MD: Resolution of soluble cyclic nucleotide phosphodiesterase isoenzymes, from liver and hepatocytes, identifies a novel IBMX-insensitive form. Biochem Pharmacol 38: 4123–4136, 1989

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Katano, Y., Endoh, M. (1993). Cyclic AMP Metabolism in Intact Rat Ventricular Cardiac Myocytes: Interaction of Carbachol with Isoproterenol and 3-Isobutyl-L-Methylxanthine. In: Yazaki, Y., Mochizuki, S. (eds) Cellular Function and Metabolism. Developments in Molecular and Cellular Biochemistry, vol 9. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3078-7_26

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-3078-7_26

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-6344-6

  • Online ISBN: 978-1-4615-3078-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics